New York, NY, August 22, 2005 – Royalty Pharma and Memorial Sloan-Kettering Cancer Center (“MSKCC”) announced today that they have completed the sale of a portion of MSKCC’s royalty interest in Neupogen® and Neulasta® worldwide for all countries except the United States, China, Japan, South Korea, North Korea and Taiwan.
Source: Original Article